Skip to main content
. 2019 Mar 25;19:265. doi: 10.1186/s12885-019-5469-8

Table 3.

Sensitivity to cisplatin, cetuximab and radiation

Cisplatin Cetuximab Radiation
Cell line IC50 (μmol/L)a Emax (%)a ID50 (Gy)a
LU-HNSCC-26 0.99 (0.89–1.1) 18 (17–19) 0.90 (0.85–0.95)
LU-HNSCC-4 10 (9.0–11) 29 (27–32) b 16 (15–17)
LU-HNSCC-5 20 (19–22) 74 (68–80) b 19 (18–21)
LU-HNSCC-6 24 (23–26) 51 (43–60) b 23 (22–25)

a(95% confidence interval)

bFrom reference [28]